Sign in
4

Changes in Ownership

PUMA BIOTECHNOLOGY, INC. Filed Acc 0001437749-25-003459

Chief Commercial Officer acquired 47,841 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ludwig Jeffrey Jerome Chief Commercial Officer 2025-02-07 Grant or award +47,841 156,792 D
Derivatives
Ludwig Jeffrey Jerome Chief Commercial Officer 2025-02-07 Grant or award · Stock Option (Right to Buy) +66,221 66,221 D
Loading xslF345X05/rdgdoc.xml…